Syndex Bio
Syndex Bio advances next-generation molecular diagnostics with its proprietary methyl-copying PCR platform.
Filter & sort
Recently funded companies in the UK tech ecosystem.
Syndex Bio advances next-generation molecular diagnostics with its proprietary methyl-copying PCR platform.
Developer of next-generation T cell receptor therapeutics for oncology and immunology.

Upfront Diagnostics develops rapid point-of-care blood tests for the rapid detection of strokes.
Wobble Genomics develops a novel approach to RNA sequencing for biotechnology applications.
Zetta Genomics builds genomic data analysis platforms for precision medicine and healthcare.

iLoF develops an artificial intelligence powered photonics platform for personalised medicine.
moa Technology develops sustainable herbicides and crop protection discovery platforms.